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Background: During the process of muscle regeneration, activated stem cells termed satellite cells proliferate, and
then differentiate to form new myofibers that restore the injured area. Yet not all satellite cells contribute to muscle
repair. Some continue to proliferate, others die, and others become quiescent and are available for regeneration
following subsequent injury. The mechanisms that regulate the adoption of different cell fates in a muscle cell
precursor population remain unclear.
Methods: We have used live cell imaging and lineage tracing to study cell fate in the C2 myoblast line.
Results: Analyzing the behavior of individual myoblasts revealed marked variability in both cell cycle duration and
viability, but similarities between cells derived from the same parental lineage. As a consequence, lineage sizes and
outcomes differed dramatically, and individual lineages made uneven contributions toward the terminally
differentiated population. Thus, the cohort of myoblasts undergoing differentiation at the end of an experiment
differed dramatically from the lineages present at the beginning. Treatment with IGF-I increased myoblast number
by maintaining viability and by stimulating a fraction of cells to complete one additional cell cycle in differentiation
medium, and as a consequence reduced the variability of the terminal population compared with controls.
Conclusion: Our results reveal that heterogeneity of responses to external cues is an intrinsic property of cultured
myoblasts that may be explained in part by parental lineage, and demonstrate the power of live cell imaging for
understanding how muscle differentiation is regulated.
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Muscle regeneration following injury occurs through
stimulation of muscle stem cells, termed satellite cells
[1]. Once activated, satellite cells proliferate to repopu-
late the injured area, and then exit the cell cycle to dif-
ferentiate and eventually fuse to form new myofibers
[1,2]. A similar series of steps occurs during muscle dif-
ferentiation in culture. Yet, in both situations not all
cells exposed to the same milieu have the same outcome.
Some myoblasts continue to proliferate, others die, and
another fraction becomes quiescent [3-6]. Because pro-
liferation and death can occur simultaneously within a
population, and can skew the fraction of cells that ultim-
ately differentiate, it has been challenging to determine
why some cells adopt one fate rather than another.* Correspondence: rotweinp@ohsu.edu
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distribution, and reproduction in any mediumMuscle differentiation in culture has been studied pri-
marily using endpoint assays that average cellular re-
sponses across the entire population. These assays
require analyzing different cohorts of cells at different
times and have inherently low temporal resolution. Fur-
thermore, most endpoint assays assume homogeneity
across the entire population. This assumption has been
increasingly questioned by single cell measurements in
other systems that find extensive variability within a
population with regard to several critical parameters, in-
cluding levels of gene or protein expression, responses
to growth factor-activated signaling pathways, cell-cycle
progression, and viability [7-11].
Live cell imaging resolves several limitations inherent
in endpoint assays by allowing the same cells to be
tracked with high temporal and spatial fidelity. This sig-
nificantly improves the amount and quality of acquired
data [12,13]. Furthermore, when combined with lineageentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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how cell fate decisions occur [8]. These approaches are
especially important when identifying mechanisms con-
trolling differentiation, in which a decision regarding the
outcome of individual cells could be based on a niche
signal, but could also be heritable or stochastic [14,15].
Here we have used live cell imaging and lineage tra-
cing to assess both proliferation and the early phases of
differentiation in the C2 muscle cell line. Our results re-
veal marked variability in both lineage size and fractional
survival, but remarkable homogeneity within individual
lineages in terms of cell fate and behavior. We also
assessed the impact of IGF-I treatment, and found that
although myoblast proliferation and survival increased,
cell fate remained similar within lineages. These experi-
ments suggest that myoblast fate is not stochastic, and
provide an approach for discerning how various treat-
ments might alter satellite cell behavior and function.
Methods
Materials
Fetal and newborn calf serum was purchased from
Hyclone (Logan, UT, USA). Horse serum, goat serum,
Dulbecco’s modified Eagle’s medium (DMEM), and PBS
were from Life Technologies (Carlsbad, CA, USA). Por-
cine gelatin was from Sigma (St. Louis, MO, USA),
Hoechst 33258 nuclear dye, from Polysciences (Warring-
ton, PA, USA), and R3-IGF-I from GroPep (Adelaide,
Australia). The primary antibody to troponin-T (CT3
from J. J-C. Lin) was purchased from the Developmental
Studies Hybridoma Bank (Iowa City, IA, USA), and the
secondary antibody, AlexaFluor 594-conjugated-goat
anti-mouse IgG, was from Life Technologies. C2 myo-
blasts were obtained from Yaffe and Saxel [16], and
HEK293FT cells were from Life Technologies. Other
chemicals were reagent grade and were purchased from
commercial suppliers.
Development of a recombinant lentivirus expressing
EGFP
A recombinant lentivirus was generated to express en-
hanced green fluorescent protein (EGFP) under control
of the EF-1α promoter using as a base Addgene plasmid
#12258 (Cambridge, MA, USA). Lentivirus was prepared
in HEK293FT cells and purified as described [17,18].
Prior to use the virus was diluted in DMEM plus 2%
fetal calf serum, and filtered through a 0.45 μM Gelman
syringe filter (Pall Life Science, Ann Arbor, MI, USA).
Cell culture
C2 myoblasts were grown and expanded on tissue cul-
ture plates coated with 0.2% gelatin in growth medium
(DMEM, 10% heat-inactivated fetal calf serum, and 10%
heat-inactivated newborn calf serum), as described[19,20]. For generation of EGFP-expressing C2 cells,
myoblasts were transduced with the EGFP lentivirus as
indicated [21]. Over 90% of cells expressed the recom-
binant protein, and EGFP expression persisted at com-
parable levels for more than five additional passages.
EGFP-positive and control C2 myoblasts were grown
separately and mixed at a 1:4 ratio prior to plating for
live cell imaging. Using a mixed population of myoblasts
at this ratio makes it possible to track labeled cells in
dense populations, and is also amenable to automated
tracking, which was not possible from bright field im-
ages. For live cell imaging experiments, cells were plated
on 6-well plates and then immediately placed in the
IncuCyte FLR (Essen Biosciences, Ann Arbor, MI, USA),
a microscopy system located inside a standard tissue cul-
ture incubator. The incubator was maintained at 37°C in
humidified air with 5% CO2. Bright field and EGFP im-
ages were acquired at 10× magnification from four loca-
tions per well at 15-min intervals in order to accurately
and completely track all labeled cells. The four locations,
which were predefined by the imaging system and con-
sistent across all experiments, were arranged as a square,
with each point equidistant from the midpoint of the
well. After 24 h in growth medium cells were washed
with PBS, and differentiation medium (DM, DMEM with
2% horse serum) was added. For selected wells, R3-IGF-I
[2 nM] was added with DM.
Image analysis
To quantify cell number a module was created using the
Cell Profiler software program [22] that loaded EGFP
images as a batch, converted images to grayscale, and
performed an illumination correction. EGFP-positive
cells in each field were identified by applying a back-
ground adaptive threshold, which separates primary ob-
jects from the background by setting a threshold at
twice the value of the mode of the histogram for pixel
intensity. Objects identified by the algorithm that were
below 15 microns in diameter were discarded from the
automated count. Cell confluence was calculated for
each field using an IncuCyte algorithm, which quantifies
the relative cell area in each bright field image.
For our studies we have defined a founder as a cell
present at the time of plating, and a lineage as all of the
progeny of a founder cell. To follow lineages, founder cells
and all progeny were manually tracked using registered
EGFP images starting from the first image obtained. Cells
around the border of each field were excluded from ana-
lysis as most tended to exit the viewing area over the
course of an experiment. Both cell division and death were
readily identified and quantified (see Figure 1). Cell death
was easily detected, as it ultimately culminated in cell lysis,
and was preceded by condensation, blebbing, and loss of
EGFP fluorescence. Additionally, an advantage of live cell
B  Myoblast Death
A  Myoblast Division
Elapsed time:  0 15 75 min604530
Elapsed time:  0 15 75 min604530
Figure 1 Visualizing myoblast division and death. (A) Time lapse images (EGFP and bright field) at 15 min increments of an EGFP-labeled
myoblast undergoing mitosis. (B) Time lapse images (EGFP and bright field) at 15 min increments of myoblast death. The arrows point to EGFP-
labeled myoblasts. The white arrows indicate cells that began to die prior to the first frame, and illustrate loss of EGFP fluorescence and
detachment over time of observation. The yellow arrows mark cells that condensed and underwent death during the period of observation. Loss
of EGFP fluorescence and detachment occurred during the subsequent 60 min (not shown).
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field could confirm that death occurred.Immunocytochemistry
To analyze muscle differentiation, plates that had been
imaged for 90 h (24 h in growth medium plus 66 h in
DM) were washed with PBS, fixed with paraformalde-
hyde for 10 min, and washed again with PBS followed by
a 90-s treatment with 50% acetone - 50% methanol, as
described [19,20]. After three additional PBS washes
wells were incubated with 0.25% goat serum in PBS
for ≥2 h to block non-specific antibody binding, followed
by incubation overnight at 4°C with troponin-T primary
antibody (1:100 dilution), washing with PBS, and incubation
for 90 min at 20°C with AlexaFluor 594-conjugated-goat
anti-mouse IgG (1:3,000 dilution) and Hoescht nuclear dye.
Cells were visualized with a Nikon Eclipse Ti-U inverted
microscope and a Nikon DS-Qi1Mc camera using the NIS
elements 3.1 software.Statistical analysis
To assess observed cell viability data, we first calculated
the number of living and dead cells among sibling pairs.
Cells that failed to divide, or that had a sibling that
underwent a second division, were not entered into this
analysis since they had no comparable sibling. This ex-
cluded 16 cells, which had a percent survival of 25%. As-
suming random death between pairs of cells, we
calculated the expected number of pairs composed of
two living myoblasts, a living and a dead cell, or two
dead cells. Expected frequencies were then compared to
observed data using a χ-squared test with two degrees of
freedom. To test for a relationship between a variable in
sibling pairs (cell cycle duration or time to death), we
calculated the Pearson correlation coefficient. To test fora correlation between random cells, we randomized the
pairings and performed the same test. Results were con-
sidered statistically significant when P ≤0.01.Results
Defining myoblast dynamics by live cell imaging
We employed live cell imaging to track myoblast prolifer-
ation and monitor survival during a differentiation time
course. To study myoblast dynamics, we plated a mixture
of unmarked myoblasts with myoblasts expressing EGFP
under control of the constitutively active EF-1α promoter,
and tracked EGFP-positive cells every 15 min using an au-
tomated cell counting algorithm (Figure 2A). We found
that a mixed population was necessary for accurate track-
ing once the cells reached confluence. We observed a pro-
gressive increase in cell number with an average doubling
time of 17.6 h during the initial 24 h of incubation
(Figure 2B). After 24 h, high serum growth medium
was replaced with low serum differentiation medium
(DM). Following addition of DM, cell number contin-
ued to increase, leading to a peak in myoblast number
between 8 and 14 h after medium was changed. Cell
number then progressively declined, but began to
stabilize by the end of the recording period after 36 h
in DM (Figure 2B). When myoblasts were plated at similar
densities these patterns were consistent across multiple lo-
cations in a single well and across independent experi-
ments (Figure 2B and Additional file 1: Figure S1A, B),
but varied in degree and timing when cells were plated at
higher or lower densities (Additional file 1: Figure S1C).
Tracking cells beyond 60 h revealed that EGFP-
positive myoblasts fused with both EGFP-expressing and
non-labeled cells to form multinucleated myotubes
(Additional file 2: Figure S2). These results were con-
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Figure 2 Defining myoblast dynamics by live cell imaging. C2
myoblasts were mixed at a 1:4 ratio with C2 cells stably infected
with an EGFP gene under control of the EF-1α promoter, and the
EGFP-expressing myoblasts were tracked at 15-min intervals using
an automated cell counting algorithm. See ‘Methods’ for additional
details. (A) Phase contrast image of EGFP-positive myoblasts (left)
and the corresponding image of the same microscopic field with
EGFP-expressing cells identified by an automated cell counting
algorithm. (B) Cell number as a function of time in culture for three
independent experiments (blue, green, and red). Each dot represents
a single measurement. (C) Percentage of maximum cell number
(closed dots) and percent confluence (open dots) as a function of
time in culture for three independent experiments (blue, green,
and red).
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neither EGFP expression nor live cell imaging compromised
muscle differentiation.
Since confluence is frequently used to establish when
DM is added, we tracked confluence and compared it tomeasures of cell number. Immediately upon plating,
confluence was approximately 20% and cell number was
approximately 25% of its maximum value (Figure 2C).
Cells soon spread out and began to divide so that by 10
h in culture when the EGFP-positive myoblast number
per field was approximately 30% to 40% of maximal, con-
fluence had reached approximately 85% to 95% (Figure 2C).
By 24 h in growth medium when the cell number was ap-
proximately 70% to 80% of maximal, confluence was ap-
proximately 99%, and it remained constant despite a
further rise in myoblast number (Figure 2C). Thus, conflu-
ence and cell number are poorly correlated.Defining myoblast population kinetics
Our automated counting algorithm measured changes in
cell number, but was unable to quantify individual in-
stances of cell death or division. In order to quantify
death and division, we manually tracked myoblasts and
their progeny over a 60-h incubation period. Both cell
division and death could be readily detected and moni-
tored (Figure 1 and Additional files 3 and 4: Movie).
During cell division, cells condensed into a circular
shape, which was followed by mitosis and emergence of
two progeny (Figure 1A). Cell death was detected by
shrinkage, blebbing, lysis, and the ultimate loss of EGFP
fluorescence (Figure 1B). Comparing manual and auto-
mated measures of the total cell number revealed similar
kinetics, thus validating the automated cell counting al-
gorithm (Additional file 1: Figure S1A, B).
Cell tracking revealed that myoblast proliferation con-
tinued well after DM was added (Figure 3A, B, Additional
file 5: Figure S3). Cell death was largely absent during the
24 h in GM, but was extensive after addition of DM so
that cell division and death were occurring simultaneously
(Figure 3C, Additional file 5: Figure S3). Addition of IGF-I
([2 nM] R3-IGF-I) with DM led to a rise in the maximal
myoblast number over controls (Figure 3A). This was a
consequence of an increase in cell division and a reduc-
tion in myoblast death (Figure 3B, C).Myoblast lineage analysis
To assess myoblast fate, we tracked 79 founder cells and
their progeny starting from the time of plating, and mea-
sured multiple kinetic parameters (Figure 4A). For the
purpose of our studies, we define lineage as all the pro-
geny of a single cell, and fate as a specific outcome (for
example, survival, death, differentiation). For each
lineage, we recorded the duration from the start of im-
aging until a founder cell divided, labeled as the time to
the first cell division (Figure 4A). This initial division
produced two cells, sibling A and sibling B. The time
from the first cell division to the division of each sibling
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Figure 3 Defining myoblast population kinetics by live cell
imaging. Individual EGFP-expressing myoblasts were studied as in
Figure 2 using manual counting. Differentiation medium (DM) was
added ± IGF-I (R3-IGF-I [2 nM]), as indicated. (A) Effect of IGF-I on total
cell number. (B) Effect of IGF-I on the frequency of cell division (DM
234 divisions; IGF-I 344 divisions). (C) Effect of IGF-I on myoblast death
(DM 208 deaths; IGF-I 154 deaths). For A to C, blue depicts control cells
and red, myoblasts incubated with IGF-I. For B and C, the number of






















Figure 4 Studying the fate of individual myoblasts. (A)
Schematic of a hypothetical myoblast lineage tree, with different
features indicated on the timeline. (B) Examples of three actual cell
lineages with progeny and fates of individual cells indicated.
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in Figure 4B.
By tracking the time from plating until the first cell
division, we found a relatively broad distribution that
ranged from 2 to 30 h (Figure 5A). This illustrated that
the start of cell division was asynchronous in the popu-
lation. We next tracked cell cycle duration using the first
full cell cycle following the division of each founder cell.
This varied across the population from 8 to 26 h with a
mean of 14.2 h (Figure 5B). The mean cell cycle duration
was shorter than the population doubling time, due in
part to eight of 79 founder myoblasts that failed to div-
ide over the entire 60-h time course.
Despite the range of cell cycle durations in the popula-
tion, there was a remarkably close correlation between
siblings (Figure 5C). This relationship was not detected
between cells paired randomly (Figure 5D). Between sib-
lings the Pearson correlation coefficient for cell cycle
duration was 0.85 (P = 1.834e-13), but between random
pairs of cells it was −0.07 (P = 0.631).
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Figure 5 The cell-cycle duration of individual C2 myoblasts is heterogeneous. Individual EGFP-expressing myoblasts were monitored at 15-min
intervals as in Figures 1 and 2. (A) Asynchronous entry of myoblasts into the cell cycle, as measured by the time from plating until the first cell division.
The number of myoblasts undergoing mitosis at a given time is plotted on the y-axis. (B) Frequency distribution of the duration of the first full cell cycle.
The number of myoblasts exhibiting a given cell cycle duration is plotted on the y-axis. (C) Close correlation (0.85, Pearson correlation coefficient) of cell
cycle duration between siblings (progeny of the same cell division; P = 1.834e-13, t = 11.14, degrees of freedom (DF) = 49). (D) No correlation was
observed for randomly paired cells (−0.07; P = 0.631, t = −0.4834, DF = 49)).
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that a significant fraction of myoblasts undergo apop-
totic death during incubation in DM [23-27]. For this
analysis, we compared the survival of 149 sibling pairs
(298 total cells). As depicted in Figure 6A, over 60% of
cells died in DM. When survival and death were
assessed on the basis of parentage, we found that 73% of
siblings had concordant fates, with 49% both dying and
24% both living, and 27% were discordant, with one
myoblast living and the other dying (Figure 6A). The
number of shared fates between siblings was significantly
larger than expected if survival occurred solely by
chance (values expected if cell death is random: 40.3%
both die, 13.3% both live, 46.4% discordant (P <0.0001)).
Similarly, even though incubation with IGF-I reduced
the percentage of cells that died (Figure 3), concordance
among siblings was 75% (50% both living and 25% both
dying, Additional file 6: Figure S4). This bias toward
concordant sibling fates was nearly identical to that ob-
served in cells incubated with DM alone (Figure 6A),
despite the percentages of both myoblasts living andboth dying being reversed (P <0.0001). These results in-
dicate that survival was not purely stochastic, but in-
stead was biased by parental lineage.
When the time from last division to death was tracked
between concordant siblings (Figure 6B), we found a close
correlation similar to that seen with cell cycle duration,
further reinforcing the importance of parental lineage.
The Pearson correlation coefficient for time to death be-
tween siblings was 0.72 (P = 2.247e-12), while by contrast
between random cells the value was 0.12 (P = 0.3271)
(Figure 6C).
Heterogeneity among myoblast lineages
We next sought to analyze how concordance between
siblings altered lineage outcomes during muscle differ-
entiation. We found that lineage sizes were unequal as
a consequence of variable rates of cell division and sur-
vival. A fraction of lineages failed to divide, another
fraction underwent fewer than two cell divisions, and
another had multiple divisions (Figure 7). Myoblast
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Figure 6 Concordance of myoblast fate. Individual EGFP-expressing myoblasts were analyzed at 15-min intervals as in Figures 1 and 2. (A) The
line plot shows the fate of each myoblast (n = 298). Each horizontal line indicates a survival timeline for a single myoblast with the left end
representing the time after the last cell division (= starting point), and the right end indicating either the time of death or survival to 36 h in DM.
Concordance or discordance of outcomes between siblings is indicated (black and blue lines reflect concordance, red discordance). The number
of identical fates between siblings was significantly larger than expected by chance (χ2 = 21.064, DF = 2, two-tailed P <0.0001). (B, C) Correlation
of time of cell death for siblings (Pearson correlation coefficient between sibling cells was 0.7196 (P <2.247e-12, t = 8.733, DF = 71) and between
randomly paired cells was 0.1163 (P <0.3271, t = 0.9868, DF = 71)).
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Figure 7 Myoblast lineages are heterogeneous. EGFP-expressing myoblasts were studied as in Figure 1. Differentiation medium (DM) was
added ± IGF-I (R3-IGF-I (2 nM)), as indicated. (A, B) Line plots showing the number of cells derived from each lineage and the outcome (alive or
dead) tracked on the y-axis. (C, D). Variation in outcomes of progeny for individual founder myoblasts leads to a shift in the population. The
population number was normalized across time. Red, founder cells and their progeny with zero surviving myoblasts; green, founders with 1 to 2
survivors; blue, lineages with ≥3 survivors.
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went 100% death, and others had mixed outcomes
(Figure 7A). Incubation of myoblasts in DM with IGF-I
led to a higher fraction of lineages with 100% survival,
but IGF-I was not able to rescue all lineages since 16
(approximately 20%) still underwent complete death
(Figure 7B). Thus, myoblast lineage size and viability
were variable.
To assess how heterogeneity in lineage size or survival
might be reflected in the total population after a differ-
entiation time course, we plotted the number of living
myoblasts in each lineage over time, grouping lineages
according to outcome. We found that the population
was evenly represented by each of the founder cell line-
ages during incubation in growth medium, but not after
addition of DM. One group of myoblasts, comprising
approximately 40% of the initial population (Figure 7C,
green tracing), maintained a similar representation for
the entire culture period, while another equivalently
sized group of founders failed to have one cell survive
after incubation in DM (Figure 7C, red). In contrast, a
third group significantly expanded from approximately20% of the initial population to approximately 60% of
the final cohort (Figure 7C, red). Thus, the overall popu-
lation at the end of the experiment differed substantially
from the population at the start.
In myoblasts incubated in DM plus IGF-I the relative
number of lineages in each group was different. IGF-I
treatment resulted in only 20% of founders not being
represented in the final population, and 57% of founders
comprised 85% of the final group (Figure 7D). Thus,
addition of IGF-I in DM maintained the myoblast
lineage distribution so that it more closely resembled the
population at the start.
Discussion
Here we have used live cell imaging and lineage tracing
to address the dynamics of muscle cell proliferation and
survival in the C2 myoblast cell line. We find a wide
variation in the rate and extent of both proliferation and
viability of myoblasts derived from different parental
cells, but concordant behavior in cells arising from the
same parents. As a consequence, the population of myo-
blasts undergoing differentiation varied substantially
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Addition of IGF-I to DM reduced population heterogen-
eity primarily by sustaining myoblast viability, and thus
increased the number and sizes of surviving lineages. As
a result, the terminal population more closely resembled
the cohort of myoblasts at the start than it did in un-
treated cells. Our observations reveal that under stand-
ard treatment protocols extensive heterogeneity is an
intrinsic property of cultured myoblasts, and that an ef-
fect of IGF-I is to decrease this variability.
Myoblast population features
We found that cell cycle durations were heterogeneous
across the population and that cell division continued after
DM was added. The average cell cycle duration of the
population in growth medium was 14.2 h. This value
matches doubling times of C2 myoblasts obtained by other
approaches, including labeling of DNA synthesis and direct
cell counting [23], but was easier to acquire and potentially
more accurate, since individual myoblasts were tracked ra-
ther than averaging multiple time points from different
groups of cells. Despite agreement of our data with previ-
ous observations, we found that the cell cycle duration of
individual myoblasts varied extensively (range, 8–26 h), and
that approximately 10% of the founder cells failed to divide
once over the entire 60-h tracking period. Remarkably,
these observations are similar to results obtained with satel-
lite cells derived from dissociated single muscle fibers [28],
where both the onset of proliferation and individual cell
cycle durations varied in the population (range, 5.1-17.8 h),
and approximately 16% of cells failed to divide once [28].
By assessing myoblast lineage, we observed that there
was a close correlation between the cell cycle durations
of siblings (Figure 5C), in remarkable agreement with an
observation noted more than 25 years ago in primary
quail myoblasts [29]. These similarities between cells of
shared parentage in both primary myoblasts and a muscle
cell line point to the potential importance of heritability
and the immediate environment in regulating cell fate.
Myoblast differentiation requires exit from the cell cycle
in G1 [30-32]. Since our data showed that cell division con-
tinued well after addition of DM in a fraction of cells, this
indicates that the onset of muscle differentiation is hetero-
geneous. Furthermore, since IGF-I treatment prolonged
the time of cell division, it is likely to increase the duration
over which cells exit the cell cycle (Figure 3B). This prob-
lem of variability is further compounded by methods that
rely on confluence to mark the time when DM should be
added [33,34], since confluence is relatively difficult to visu-
ally quantify, and as seen here, small changes in confluence
can equate to large differences in cell numbers (Figure 2B).
It is well known that a fraction of cultured myoblasts
succumb to apoptotic cell death during incubation in
DM [23-25,35]. Similarly, it has been reported that inresponse to muscle injury in vivo, satellite cell prolifera-
tion is followed by a period of satellite cell death [6]. We
found that the net decline in cell number following 36 h
in DM was approximately 35%. This is in line with the
20% to 30% value previously reported with endpoint
methods, including TUNEL assays, cell counting, and
‘live-dead’ staining [25,35]. Yet, by tracking both the div-
ision and death of individual cells, we found that over
60% of the population died during 36 h in DM, with the
majority of death occurring during the initial 15 h
(Figure 3C). This value differed substantially from cell
number calculations because of concurrent proliferation of
other EGFP-labeled myoblasts during incubation in DM.
Thus, we suggest that traditional apoptosis assays under-
estimate the extent of myoblast death by failing to account
for ongoing proliferation of other cells in the culture.
By identifying and tracking individual myoblasts and
their offspring, we found that cell death was not ran-
dom. Rather, siblings were biased toward adopting con-
cordant fates after incubation in DM. The tendency
toward common outcomes was maintained even in
cells exposed to IGF-I, despite enhanced myoblast sur-
vival from IGF-I treatment (Figure 3C, Additional file 4:
Figure S4). The mechanisms responsible for these biases
are unclear, but could arise from genetic or epigenetic dif-
ferences, or from environmental influences. We suspect
that a fraction of the bias may be explained by similar
levels or activity of the IGF-I - PI3-kinase - Akt signaling
pathway between related cells, since exposure to IGF-I re-
duced myoblast death, but maintained concordant fates
between siblings. It is therefore possible that cells of
shared parentage inherit similar amounts of signaling
components, and/or share epigenetic or genetic alter-
ations that affect regulation of this pathway. This is
consistent with observations that cell siblings adopt
concordant fates in response to apoptosis-inducing
agents because of a common inheritance of proteins
from their mother [7,8]. Alternatively, as siblings share
a similar microenvironment, we cannot exclude the
possibility that paracrine factors also contribute to the
regulation of cell survival.
The main impact of cell death not being random was a
dramatic change in the composition of the myoblast
population by the end of the culture period. This was
not apparent during the initial 24 h of incubation in
growth medium because myoblast viability was complete
and most of the cells underwent at least one cell division
(Figure 5). Variability arose, however, during the subse-
quent 36 h in DM, as distinct subpopulations developed
rapidly from heterogeneous cell division coupled with
variable survival. This led to substantial differences in the
contributions of different lineages to the final myoblast
population (Figure 6A, 7, Additional file 6: Figure S4).
Our results suggest that measurements that average
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course, such as immunoblots or gene expression assays,
can obscure the properties of subpopulations.
Impact of IGF-I on myoblast proliferation, survival, and
differentiation
IGF-I exerts potentially contradictory effects on muscle cells,
including promoting both proliferation and differentiation
[33]. Our observations suggest one resolution to this prob-
lem. Analysis of the onset of the last division revealed that
IGF-I led to an average delay of approximately 5 h com-
pared with untreated controls (Figure 3B, Additional file 6:
Figure S4). As this delay did not lead to more than one add-
itional cell division, our interpretation is that the main action
of IGF-I is to maintain myoblast survival so that otherwise
vulnerable cells are able to complete a single final round of
replication. These effects of IGF-I complicate comparisons
with untreated cells, as both fractional myoblast survival
and the starting points for differentiation are different. Fu-
ture applications of reporters for different aspects of differ-
entiation are needed to improve our understanding of the
kinetics and regulation of muscle differentiation by separat-
ing out these confounding factors.
Satellite cell fate and muscle regeneration
An important question in skeletal muscle biology is how
satellite cell fate is regulated during muscle regeneration.
Following injury, satellite cells must divide sufficiently to
insure adequate numbers of differentiating myoblasts for
immediate muscle repair, but also must maintain a re-
serve population for regeneration after subsequent injury
[4,6,36]. Thus, multiple cell fate decisions are necessary
to ensure adequate current and future muscle repair.
Live cell imaging has begun to be applied to this ques-
tion, and has revealed the importance of asymmetric
and symmetric satellite cell divisions [14,37,38]. Other
studies have shown that the satellite cell population is
very heterogeneous, not only in terms of its behavior in
response to proliferative or migratory cues [28,39], but
also with respect to cell of origin [36], and surface pro-
tein expression [6,40]. Thus both environmental and
genetic factors potentially play influential regulatory
roles in muscle regeneration through effects on satellite
cells. Elucidating how this heterogeneity impacts the de-
cisions that lead to satellite cell differentiation will be
critical to understanding the dynamics of muscle regen-
eration and how under certain circumstances such as
aging this process can go awry.
Conclusions
We have used live cell imaging and lineage tracing to as-
sess both proliferation and the early events of differenti-
ation in C2 myoblasts. Our results reveal marked
variability in lineage size and fractional survival, butremarkable homogeneity within individual lineages in
terms of cell fate. Treatment with IGF-I increased myo-
blast number by maintaining viability and by stimulating
a fraction of cells to complete one additional cell cycle
in DM, and as a consequence reduced the variability of
the terminal population compared with controls. Our re-
sults reveal that heterogeneity is an intrinsic property of
cultured myoblasts, and demonstrate the power of live
cell imaging to provide insights into the regulation of
muscle differentiation.
Additional files
Additional file 1: Figure S1. Characterizing myoblasts by live cell
imaging. C2 cells were mixed at a 1:4 ratio with C2 myoblasts stably
infected with an EGFP gene under control of the EF-1α promoter. The
EGFP-expressing myoblasts were tracked at 15-min intervals. (A)
Concordance between results of manual and automated cell counting.
Cells were incubated for 60 h, with DM ± IGF-I (R3-IGF-I [2 nM]) being
added for the last 36 h (red traces). Solid lines represent manual tracking
of lineages and dots represent automated counting. (B) Reproducibility
of automated cell counting. Four wells were plated with an identical
number of cells, and were incubated for 60 h, with DM ± IGF-I being
added for the last 36 h. (C) Effects of plating density on myoblast
dynamics. Cells were plated at varying concentrations, and EGFP-positive
cells were identified by automated counting at 15-min intervals for 60 h.
Additional file 2: Figure S2. EGFP-expressing myoblasts undergo
differentiation. Confluent myoblasts were incubated in DM for 66 h. (A)
Live cell images of EGFP fluorescence were captured (10× magnification).
(B) Differentiating myoblasts were fixed and stained with antibodies to
troponin-T (red), and nuclei were stained with Hoescht dye (blue, 100×
magnification).
Additional file 3: Movie 1. Live cell imaging of C2 myoblasts. Live cell
imaging of C2 myoblasts for 60 h (24 h in growth medium, 36 h in DM).
Fluorescent images were captured every 15 min.
Additional file 4: Movie 1. Live cell imaging of C2 myoblasts with
manual tracking overlay. Live cell imaging of C2 myoblasts for 60 h (24 h
in growth medium, 36 h in DM). Fluorescent images were captured every
15 min.
Additional file 5: Figure S3. Reproducibility of myoblast dynamics by
live cell imaging. Individual EGFP-expressing myoblasts were manually
tracked at 15-min intervals in three independent experiments, as in
Figure 3. Left panels: cell number measured as a function of time in
culture. Center panels: frequency of cell division analyzed as a function of
time in culture. Right panels: frequency of myoblast death recorded as a
function of time in culture.
Additional file 6: Figure S4. IGF-I promotes myoblast proliferation and
enhances viability. Individual EGFP-expressing myoblasts were analyzed at
15-min intervals as in Figures 3 and 6. The line plot shows the fate of
each myoblast (n = 372). Each horizontal line indicates a survival timeline
for a single myoblast with the left end representing the time after the
last cell division (= starting point), and the right end indicating either the
time of death or survival to 36 h in DM. Concordance or discordance of
outcomes is indicated (black and blue lines reflect concordance, red
discordance). The number of identical fates between siblings was
significantly larger than expected by chance (χ2 = 45.581, DF = 2, two-tailed
P <0.0001).
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